Home > News > Nanogen Receives $25 Million Equity Financing Commitment
May 10th, 2006
Nanogen Receives $25 Million Equity Financing Commitment
Abstract:
Nanogen, Inc. (Nasdaq: NGEN), developer of advanced diagnostic products, announced today that it
has received a commitment for up to $25 million in common stock equity financing from Azimuth Opportunity Ltd. Subject to the terms and conditions of a purchase agreement between Nanogen and Azimuth Opportunity, over the next eighteen months, Nanogen may sell registered shares of its common stock, at its discretion, to Azimuth Opportunity at a small discount from market price.
Source:
prnewswire
Bookmark:
| Related News Press |
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||